Insights into tumor expression and distribution of FRα and its emerging roles in cancer growth and metastasis are now focusing renewed interest on this tumor-associated antigen as a potential target and tumor marker for solid tumours such as ovarian, lung and basal breast cancers. This evidence concerns the gene FOLR1 and neoplasm.